Event Report: "TOKYU KABUKICHO TOWER 2025 New Year's Eve" held as TOKYU KABUKICHO TOWER 's first New Year's Eve event across multiple floors
TOKYU KABUKICHO TOWER (hereinafter referred to as the "facility"), operated by TST Entertainment Inc. (Shinjuku-ku, Tokyo; President and CEO: Koichi Honda), provides entertainment content that can be enjoyed by a wide range of customers from both Japan and abroad, with the aim of transforming Kabukicho into a "global entertainment city."
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109016504/en/
Kabukicho Cine City Plaza at the moment of New Year's celebration (Photo: Business Wire)
The "TOKYU KABUKICHO TOWER 2025 New Year's Eve" event was held from December 31, 2024 to January 1, 2025. The nightclub "ZEROTOKYO" featured London-based music producer SBTRKT, and the crowd enjoyed a grand start to the year 2025 with a world-class musical experience. Other events included DJ live performances and shows at "Shinjuku Kabuki Hall ‒ Kabuki Yokocho", a New Year's Eve traditional soba noodle menu, live viewing of a classic concert at a movie theater, and a countdown party at a hotel restaurant. Taking advantage of the unique characteristics of this hotel and entertainment complex, the entire facility offered a variety of non-verbal entertainment for guests to enjoy.
In addition, at the Kabukicho Cine City Plaza adjacent to the facility, a countdown was staged by linking ZEROTOKYO's DJ performance with an outdoor vision screen. As the new year approached, the countdown to midnight was displayed on the screen to kick off the celebration. The plaza was filled with the roar of approximately 5,000 people who welcomed 2025 in a lively atmosphere.
We will continue our efforts to deliver entertainment content that can be enjoyed by a wide variety of customers both in Japan and overseas.
There was great excitement inside TOKYU KABUKICHO TOWER even after the countdown!
Even after midnight, the venue was packed with people celebrating the New Year's holiday with performances by "KAWAII MONSTER PARTY" performers on the center stage of the 2nd floor of "Shinjuku Kabuki Hall ‒ Kabuki Yokocho". The performers invited the audience to join them on stage in a surprise performance as the excitement at the venue reached its peak. "namco TOKYO" on the 3rd floor held a special stage for "DEN-ON-BU," a dance music-themed character project, where DJs played anime and game songs. Not only fans of "DEN-ON-BU" from Japan but also visitors from all over the world gathered around the stage to enjoy the show. The entire facility was a New Year's Eve event that could be enjoyed by people of all nationalities.
Check here for images of the facility: https://www.instagram.com/tokyukabukichotower_official/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250109016504/en/
Contacts
TOKYU KABUKICHO TOWER PR Office (in SUNNY SIDE UP Inc.)
tokyu-kabukicho-towerpr@ssu.co.jp
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore10.1.2025 13:30:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Zai Lab Limited (Nasdaq: ZLAB; HKEX: 9688) today announced an exclusive collaboration and license agreement for the development and commercialization of Vertex’s povetacicept (pove) in mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore (the licensed territory). Pove is a recombinant fusion protein therapeutic and dual antagonist of BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) with best-in-class potential being studied for the treatment of Immunoglobulin A nephropathy (IgAN) and other B cell-mediated diseases. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250110168811/en/ Under the terms of the agreement, Vertex will receive an upfront payment, as well as certain regulatory milestone payments and tiered royalties, on net sales of pove in the region of focus for Zai Lab. Zai Lab will utilize its extensive research and deve
Compass Pathways Announces Pricing of Underwritten Offering10.1.2025 13:01:00 CET | Press Release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten offering of 24,014,728 American Depositary Shares (“ADSs”) and in lieu of ADS, to certain institutional investors, pre-funded warrants to purchase up to 11,044,720 ADSs. Each ADS and pre-funded warrant shall be accompanied by a warrant (“ADS Warrant”) to purchase one ADS, which has an exercise price of $5.796 per ADS, representing a 40% premium to the last sale price and will be exercisable following a specified data milestone. The offering price is $4.275 per ADS and accompanying ADS Warrant, and $4.2649 per pre-funded warrant and accompanying ADS Warrant. All of the securities are to be sold by Compass. The offering is expected to close on or about January 13, 2025, subject to satisfaction of customary closing conditions. The offering was led by Deep Track Capital and included participation
Ronald S. Lauder to Retire from The Estée Lauder Companies’ Board of Directors10.1.2025 12:45:00 CET | Press Release
The Estée Lauder Companies (NYSE: EL) announced today that Ronald S. Lauder will retire from the Company’s Board of Directors (the “Board”) effective immediately. Pursuant to the stockholders’ agreement among Lauder family members and the Company, Mr. Lauder has the right to designate two directors of the Company. His daughter Jane Lauder will continue to serve on the Board in her current position, and he has named his son-in-law Eric Zinterhofer, who is married to his daughter Aerin Lauder, to be his second designee. In connection with Mr. Lauder’s retirement from the Board and his designation of Mr. Zinterhofer as his nominee, the Board has elected Mr. Zinterhofer effective immediately. Mr. Lauder will remain Chairman of Clinique Laboratories, LLC. Mr. Zinterhofer joins the Board with extensive financial, investing and global business experience, and is currently a Founding Partner of Searchlight Capital Partners. He serves on the Investment Committee, Operating Committee and Valuati
GlobalLogic Announces Leadership Change: Srini Shankar Appointed as President and Chief Executive Officer10.1.2025 11:30:00 CET | Press Release
GlobalLogic Inc., a Hitachi Group Company and leader in Digital Engineering, today announced that GlobalLogic’s Chief Business Officer (CBO) and Head of Global Industries, Srinivas (Srini) Shankar has been appointed its new President and CEO, effective February 3, 2025. Srini will succeed Nitesh Banga, who has decided to step down to pursue new opportunities outside of Hitachi and GlobalLogic. Nitesh joined GlobalLogic in June 2018. His leadership and expertise helped GlobalLogic achieve significant organic and inorganic growth, expand the organization’s offerings, capabilities, and footprint, and evolve as a global leader in Design-Led Digital Engineering. Nitesh also played a central role in GlobalLogic’s acquisition by Hitachi and has been paramount to the ongoing synergy success between GlobalLogic and Hitachi, including the expansion of GlobalLogic's business in Japan. “I am proud of the significant growth we achieved, the purposeful impact we’ve engineered for our clients and the
Ant Group Extends Partnership with Olympic Tennis Champion Qinwen Zheng as Brand Ambassador10.1.2025 07:57:00 CET | Press Release
Ant Group today announced the extension of its successful partnership with Qinwen Zheng, the rising tennis legend and Olympic gold medalist. This renewed collaboration underscores the shared commitment to striving for excellence, while inspiring and engaging young people together. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250109266663/en/ (Photo: Business Wire) “I am excited to continue my partnership with Ant Group as a brand ambassador,” said Zheng. “Ant Group's unwavering commitment to inclusivity and equal development opportunities for diverse groups, particularly women and teenagers, aligns perfectly with my values. I look forward to our next chapter together to inspire even more young people to pursue their dreams.” In 2024, Zheng made history by winning the gold medal in women's singles at the Paris Olympics, becoming the first Asian tennis player to secure an Olympic singles title. Her perseverance, courage, and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom